Brian Feth's guest appearances

Brian Feth

Finding Genius Podcast

KGI: Innovation in Applied Life Sciences & Healthcare

FutureTech Podcast

Kelly Glazer Baron

Samantha Nazareth

Kevin Kastelnik

Kelly Dorfman

Paul Weiss

David Cave

Niny Rao

Gaetan Chevalier

Azizi A. Seixas

Christopher Barrett

Kim Kush

Adrian Bejan

Jake Kushner

William B. Miller

J.A. Jones

OwlTail

On today's episode of the KGI Podcast, Sandi Mero chats with Brian Feth, chief executive officer at Xcell Biosciences. Brian earned a Master of Business and Science at KGI. Brian is a life sciences entrepreneur passionate about creating transformative change in human health through powerful new technologies to better understand and destroy cancer. His team at Xcell Biosciences is working on a new generation of immunotherapy development technologies, utilizing a novel platform they've built for expanding and manipulating a range of patient-derived cell types.

On today's episode of the KGI Podcast, <a href="https://www.kgi.edu/people/sandi-mero/" rel="nofollow" target="_blank">Sandi Mero</a> chats with <a href="https://www.linkedin.com/in/brianfeth/" rel="nofollow" target="_blank">Brian Feth</a>, chief executive officer at <a href="https://www.xcellbio.com/" rel="nofollow" target="_blank">Xcell Biosciences</a>. Brian earned a Master of Business and Science at KGI. Brian is a life sciences entrepreneur passionate about creating transformative change in human health through powerful new technologies to better understand and destroy cancer. His team at Xcell Biosciences is working on a new generation of immunotherapy development technologies, utilizing a novel platform they've built for expanding and manipulating a range of patient-derived cell types.

#61 - Brian Feth

James Lim

Xcellbio has developed a proprietary cell control system for use in research, drug development and regenerative medicine. The founders discuss their work in the control of tumor cells, stem cells, and immune cells. Xcellbio’s main focus is the growth of primary human cells outside of the body, which can then be trained to attack disease-causing cells, then returned to the body to eliminate the disease. Their technology is currently in use for cancer research.

Xcellbio has developed a proprietary cell control system for use in research, drug development and regenerative medicine. The founders discuss their work in the control of tumor cells, stem cells, and immune cells. Xcellbio’s main focus is the growth of primary human cells outside of the body, which can then be trained to attack disease-causing cells, then returned to the body to eliminate the disease. Their technology is currently in use for cancer research.

Brian Feth & James Lim, Founders – Xcellbio

Xcellbio has developed a proprietary cell control system for use in research, drug development and regenerative medicine. The founders discuss their work in the control of tumor cells, stem cells and immune cells. Xcellbio's main focus is the growth of primary human cells outside of the body, which can then be trained to attack disease-causing cells, then returned to the body to eliminate the disease. Their technology is currently in use for cancer research.

Brian Feth & James Lim, Founders - Xcellbio